131 related articles for article (PubMed ID: 7686696)
21. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery.
Cosentino F; Sill JC; Katusić ZS
Am J Physiol; 1993 Feb; 264(2 Pt 2):H413-8. PubMed ID: 8383455
[TBL] [Abstract][Full Text] [Related]
22. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation.
Stubbs CM; Waldron GJ; Connor HE; Feniuk W
Br J Pharmacol; 1992 Apr; 105(4):875-80. PubMed ID: 1380374
[TBL] [Abstract][Full Text] [Related]
24. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine.
Mügge A; Lopez JA; Piegors DJ; Breese KR; Heistad DD
Am J Physiol; 1991 Jan; 260(1 Pt 2):H242-7. PubMed ID: 1704195
[TBL] [Abstract][Full Text] [Related]
25. Importance of nitric oxide in canine femoral circulation: comparison of two NO inhibitors.
Kirkebøen KA; Naess PA; Christensen G; Kiil F
Cardiovasc Res; 1992 Apr; 26(4):357-61. PubMed ID: 1638567
[TBL] [Abstract][Full Text] [Related]
26. Cerebroarterial relaxations mediated by nitric oxide derived from endothelium and vasodilator nerve.
Toda N; Ayajiki K; Okamura T
J Vasc Res; 1993; 30(2):61-7. PubMed ID: 7684937
[TBL] [Abstract][Full Text] [Related]
27. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A
J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366
[TBL] [Abstract][Full Text] [Related]
28. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
[TBL] [Abstract][Full Text] [Related]
29. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide-mediated retinal arteriolar and arterial dilatation induced by substance P.
Kitamura Y; Okamura T; Kani K; Toda N
Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2859-65. PubMed ID: 7689544
[TBL] [Abstract][Full Text] [Related]
31. Dilatation of cerebral arterioles in response to lipopolysaccharide in vivo.
Brian JE; Heistad DD; Faraci FM
Stroke; 1995 Feb; 26(2):277-80; discussion 281. PubMed ID: 7530388
[TBL] [Abstract][Full Text] [Related]
32. Subarachnoid hemorrhage and endothelial L-arginine pathway in small brain stem arteries in dogs.
Katusić ZS; Milde JH; Cosentino F; Mitrović BS
Stroke; 1993 Mar; 24(3):392-9. PubMed ID: 8446976
[TBL] [Abstract][Full Text] [Related]
33. Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels.
Tagawa T; Imaizumi T; Endo T; Shiramoto M; Hirooka Y; Ando S; Takeshita A
J Clin Invest; 1993 Sep; 92(3):1483-90. PubMed ID: 8376600
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.
Joannides R; Haefeli WE; Linder L; Richard V; Bakkali EH; Thuillez C; Lüscher TF
Circulation; 1995 Mar; 91(5):1314-9. PubMed ID: 7867167
[TBL] [Abstract][Full Text] [Related]
35. Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarterial muscle.
Toda N; Okamura T
Biochem Biophys Res Commun; 1990 Jul; 170(1):308-13. PubMed ID: 2164808
[TBL] [Abstract][Full Text] [Related]
36. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
Steinberg HO; Brechtel G; Johnson A; Fineberg N; Baron AD
J Clin Invest; 1994 Sep; 94(3):1172-9. PubMed ID: 8083357
[TBL] [Abstract][Full Text] [Related]
37. Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs.
Baskaya MK; Suzuki Y; Anzai M; Seki Y; Saito K; Takayasu M; Shibuya M; Sugita K
J Cereb Blood Flow Metab; 1995 Sep; 15(5):827-34. PubMed ID: 7673375
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide, but not vasopressin V2 receptor-mediated vasodilation, modulates vasopressin-induced renal vasoconstriction in rats.
Loichot C; Cazaubon C; De Jong W; Helwig JJ; Nisato D; Imbs JL; Barthelmebs M
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):319-26. PubMed ID: 10731046
[TBL] [Abstract][Full Text] [Related]
39. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
40. Isoflurane produces endothelium-independent relaxation in canine middle cerebral arteries.
Flynn NM; Buljubasic N; Bosnjak ZJ; Kampine JP
Anesthesiology; 1992 Mar; 76(3):461-7. PubMed ID: 1539859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
